Glipizide Pharmacokinetics in Healthy and Diabetic Volunteers

Tropical Journal of Pharmaceutical Research

Volumn 10, Issue 2, 2011, Pages 147-152

  Atif, Muhammad ^a   Ahmad, Mahmood ^b   Qamar uz zaman, M ^b   Asif, Muhammad ^b   Sulaiman, Syed Azhar Syed ^a   Shafie, Asrul Akmal ^a   Masood, I ^a   Minhas, Usman ^b   Us saqib, Najam ^c  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b THE ISLAMIA UNIVERSITY OF BAHAWALPUR   (Pakistan)

^c Ministry of Health   (Pakistan)

Author keywords

Bioavailability; Glipizide; Pharmacokinetics; Plasma; Reversed Phase High performance liquid chromatography

Indexed keywords

GLIPIZIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; HUMAN; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NON INSULIN DEPENDENT DIABETES MELLITUS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 79955942083     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: 10.4314/tjpr.v10i2.66555     Document Type: Article

References (21)

1. DeFronzo RA, Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 2004; 88(4): 787-835.
2. Korc M. Update on diabetes mellitus. Dis Markers 2004; 20(3): 161-165.
3. Lebovitz HE. Glipizide: a second-generation sulfonylurea hypoglycemic agent. Pharmacology, pharmacokinetics and clinical use. Pharmacotherapy 1985; 5(2): 63-77.
4. British Pharmacopoeia 1999. Stationery Office Books; 99 edn (April 1999; p. 701).
5. Barzilai N, Groop PH, Groop L, DeFronzo R. A novel mechanism of Glipizide sulfonylurea action: decreased metabolic clearance rate of insulin. Acta Diabetol 1995; 32(4): 273-278.
6. th edn, McGraw Hill; 1996. pp 1507-1519, 1746.
7. Wahlin BE, Melander A, Sartor G, Schersten B. Influence of food intake on the absorption and effect of Glipizide in diabetics and in healthy subjects. Eur J Clin Pharmacol 1980; 18(3): 279-283.
8. Anthony CM, David MO, Brian W. Clarke's Analysis of Drug and Poisons, 3rd ed, The Pharmaceutical Press, UK; 2004. p 1081.
9. Suheil Z, Munib S, Ali Q, Munir G, Bassan A, Maha T, Majed AR, Hasan MA. Comparative single dose bioequivalence study of two brands of glipizide. Curr Therapeut Res 1995; 56(1): 38-46.
10. Otsman J, Christenson B, Jansson L. The antidiabetic effect and pharmacokinetic properties of glipizide. Acta Med Scand 1981; 210: 173-180.
11. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Individual sulfonyl-ureas and serious hypoglycemia in older people. J Am Geriatr Soc 1996; 44(7): 751-755.
12. Kobayashi KA, Bauer LA, Horn JR, Opheim K, Wood F Jr, Kradjan WA. Glipizide pharmacokinetics in young and elderly volunteers. Clin Pharm 1988; 7(3): 224-228.
13. Kradjan WA, Kobayashi KA, Bauer LA, Horn JR, Opheim KE. Wood FJ. Glipizide pharmacokinetics: effects of age, diabetes, and multiple dosing. J. Clin. Pharmacol 1989; 29: 1121-1127.
14. Elisabeth WH, Arne M. High performance liquid chromato-graphic determination of Glipizide and some other sulfonylureas in serum. J Chromatography 1979; 162: 541-546.
15. Emilsson H. High-performance liquid chromategraphic determination of Glipizide in human plasma and urine. J Chromatogr 1987; 421(2): 319-326.
16. Sener A. G, Akkan W. J, Malaisse. Standardized procedure for assay and identification of hypoglycemic sulfonylureas in human plasma. Acta Diabetol 1995; 32: 64-68.
17. Matthew DW, Jonathan GH, Iain KM. Pharmacokinetic variation. Anaesthesia & Intensive Care Medicine 2008; 9(8): 369-371.
18. Dhawan, Singh B, Garg SK, Hota D, Dash RJ, Singla AK, Sinha VR. Bioavailability of immediate-and extended-release formulations of glipizide in healthy male volunteers. Clin Pharmacokinetic 2006; 45(3): 317-324.
19. Jaber LA, Ducharme MP, Halapy H. The effects of obesity on the pharmacokinetics and pharmacodynamics of glipizide in patients with non-insulin dependent diabetes mellitus. Therapeutic Drug Monitoring 1996; 18(1): 6-13.
20. Pentikainen PJ, Neuvonen PJ, Penttila A. Pharmacokinetics and pharmacodynamics of glipizide in healthy volunteers. Int J Clin Pharmacol Ther Toxicol 1983; 21(2): 98-107
21. Donald J Birkett. Pharmacokinetics Made Easy, 2nd edition, McGraw Hill Australia; 2002; p 18.